Article
Challenges in Expression and Purification of Functional Fab Fragments in E. coli: Current Strategies and Perspectives
2022-04-09
Abstract excerpt
Microbial host systems remain the most efficient and cost-effective chassis for biotherapeutics production. Escherichia coli is often the preferred host due to ease of cloning, scale-up, high product yields, and most importantly, cost-effective cultivation. E. coli often experience difficulties in producing biologically active therapeutics such as Fab fragments, which require protein folding and subsequent three-d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d79ccac8-4bc5-5ae7-818a-939a059b0f4d
- DOI
- 10.3390/fermentation8040175
